Chong Kun Dang Pharmaceutical Corp. Stock: price and insider trades · South Korea
종근당
1 insider bought €23.2M of shares over the last 90 days, the latest by 이주원, filed 08 Oct 2026.
Who traded when
BuySaleSince the insiders bought
- -28.2%Entry ₩87,900 · Close 30 Oct 2026 ₩63,100
- -28.2%Entry ₩87,900 · Close 30 Oct 2026 ₩63,100
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 528,807 sharesShareKRXDART:20261008000694Canonical exit: 6 Jan 2027 (T+90)
- 1,318,807 sharesShareKRXDART:20261008000683
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- ●Executives0DART
- 138,618 sharesKRXDART:20260701000355
- 995,402 sharesKRXDART:20260626000723
- ●Executives0DART
- 159,672 sharesKRXDART:20260601001904Canonical exit: 24 Aug 2026 (T+90)
- 0KRXDART:20260430001234
- 0KRXDART:20260421000334
- 0KRXDART:20260407002688
- 0KRXDART:20260402001459
- 12,000 shares@ ₩87,998.000.11% mcap39.3% of flowShareKRXDART:20260323001384Canonical exit: 16 Jun 2026 (T+90)
- 31,000 shares0.28% mcap53.8% of flowKRXDART:20260323000966Canonical exit: 17 Jun 2026 (T+90)
- 19,000 shares@ ₩85,134.10530.17% mcap60.7% of flowShareKRXDART:20260313001236Canonical exit: 8 Jun 2026 (T+90)
- ●Executives0DART
- 26,000 shares@ ₩91,225.3820.26% mcap100.0% of flowShareKRXDART:20260305001322Canonical exit: 28 May 2026 (T+90)
- 26,000 shares0.24% mcap46.2% of flowKRXDART:20260305001161Canonical exit: 26 May 2026 (T+90)
- ●Executives0DART
25 of 78 declarations
About Chong Kun Dang Pharmaceutical Corp.
Purchases at 종근당 (Chong Kun Dang Pharmaceutical Corp.) are carried by two filers: 이장한, who appears with the function 회장, and the company 종근당홀딩스, which totals 27 purchases across 30 filings. The three largest purchases with an amount are two by 이장한, on March 19, 2026 (EUR 1,512,540) and February 25, 2026 (EUR 1,299,480), and one by 종근당홀딩스 on February 27, 2026 (EUR 1,401,769). Five purchases carry an amount, EUR 5,776,250 in all.
A South Korean pharmaceutical group listed on the Korea Exchange, 종근당 has a market capitalisation of KRW 882.8 billion; 45% of the capital belongs to filers. The register lines up 71 filings, published from March 22, 2021 to October 8, 2026, by 6 filers. On the market there are 42 purchases against 4 sales, or 91% purchases; 25 filings are of another nature.
Read moreShow less
On February 7, 2025, three filers bought on the same day. On the calendar, 2026 is the busiest year with 20 filings, ahead of 2022 and 2023 (13 each). The last twelve months add up to 26 filings, of which 14 purchases and 3 sales. Allow a median of 6 days between the trade and its publication.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
